These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26440540)

  • 1. Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children.
    Bahr SM; Tyler BC; Wooldridge N; Butcher BD; Burns TL; Teesch LM; Oltman CL; Azcarate-Peril MA; Kirby JR; Calarge CA
    Transl Psychiatry; 2015 Oct; 5(10):e652. PubMed ID: 26440540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome.
    Skonieczna-Żydecka K; Łoniewski I; Misera A; Stachowska E; Maciejewska D; Marlicz W; Galling B
    Psychopharmacology (Berl); 2019 May; 236(5):1491-1512. PubMed ID: 30460516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure.
    Bahr SM; Weidemann BJ; Castro AN; Walsh JW; deLeon O; Burnett CM; Pearson NA; Murry DJ; Grobe JL; Kirby JR
    EBioMedicine; 2015 Nov; 2(11):1725-34. PubMed ID: 26870798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin prevents obesity through modulation of gut microbiota in mice.
    Xu P; Wang J; Hong F; Wang S; Jin X; Xue T; Jia L; Zhai Y
    J Pineal Res; 2017 May; 62(4):. PubMed ID: 28199741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
    Moreno C; Merchán-Naranjo J; Alvarez M; Baeza I; Alda JA; Martínez-Cantarero C; Parellada M; Sánchez B; de la Serna E; Giráldez M; Arango C
    Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and safety profile of risperidone in a sample of children and adolescents.
    Margari L; Matera E; Craig F; Petruzzelli MG; Palmieri VO; Pastore A; Margari F
    Int Clin Psychopharmacol; 2013 Jul; 28(4):177-83. PubMed ID: 23689836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone-associated weight gain in children and adolescents: a retrospective chart review.
    Martin A; Landau J; Leebens P; Ulizio K; Cicchetti D; Scahill L; Leckman JF
    J Child Adolesc Psychopharmacol; 2000; 10(4):259-68. PubMed ID: 11191686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of postnatal low-dose exposure to environmental chemicals on the gut microbiome in a rodent model.
    Hu J; Raikhel V; Gopalakrishnan K; Fernandez-Hernandez H; Lambertini L; Manservisi F; Falcioni L; Bua L; Belpoggi F; L Teitelbaum S; Chen J
    Microbiome; 2016 Jun; 4(1):26. PubMed ID: 27301250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months.
    Kelly DL; Conley RR; Love RC; Horn DS; Ushchak CM
    J Child Adolesc Psychopharmacol; 1998; 8(3):151-9. PubMed ID: 9853689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population.
    Koliada A; Syzenko G; Moseiko V; Budovska L; Puchkov K; Perederiy V; Gavalko Y; Dorofeyev A; Romanenko M; Tkach S; Sineok L; Lushchak O; Vaiserman A
    BMC Microbiol; 2017 May; 17(1):120. PubMed ID: 28532414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic risperidone exposure does not show any evidence of bone mass deterioration in animal model of schizophrenia.
    Petronijevic N; Sopta J; Doknic M; Radonjic N; Petronijevic M; Pekic S; Maric N; Jasovic-Gasic M; Popovic V
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():58-63. PubMed ID: 23811489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron homeostasis during risperidone treatment in children and adolescents.
    Calarge CA; Ziegler EE; Del Castillo N; Aman M; McDougle CJ; Scahill L; McCracken JT; Arnold LE
    J Clin Psychiatry; 2015 Nov; 76(11):1500-5. PubMed ID: 26301448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychotics.
    Cuerda C; Merchan-Naranjo J; Velasco C; Gutierrez A; Leiva M; de Castro MJ; Parellada M; Giráldez M; Bretón I; Camblor M; García-Peris P; Dulín E; Sanz I; Desco M; Arango C
    Clin Nutr; 2011 Oct; 30(5):616-23. PubMed ID: 21492975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microbiome-gut-brain axis: implications for schizophrenia and antipsychotic induced weight gain.
    Kanji S; Fonseka TM; Marshe VS; Sriretnakumar V; Hahn MK; Müller DJ
    Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):3-15. PubMed ID: 28624847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral supplementation with L-glutamine alters gut microbiota of obese and overweight adults: A pilot study.
    de Souza AZ; Zambom AZ; Abboud KY; Reis SK; Tannihão F; Guadagnini D; Saad MJ; Prada PO
    Nutrition; 2015 Jun; 31(6):884-9. PubMed ID: 25933498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.
    Gebhardt S; Haberhausen M; Heinzel-Gutenbrunner M; Gebhardt N; Remschmidt H; Krieg JC; Hebebrand J; Theisen FM
    J Psychiatr Res; 2009 Mar; 43(6):620-6. PubMed ID: 19110264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of antipsychotic medications on microbiome and weight gain in children and adolescents.
    Bretler T; Weisberg H; Koren O; Neuman H
    BMC Med; 2019 Jun; 17(1):112. PubMed ID: 31215494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron deficiency in pediatric patients in long-term risperidone treatment.
    Calarge CA; Ziegler EE
    J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):101-9. PubMed ID: 23480322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.
    Arango C; Giráldez M; Merchán-Naranjo J; Baeza I; Castro-Fornieles J; Alda JA; Martínez-Cantarero C; Moreno C; de Andrés P; Cuerda C; de la Serna E; Correll CU; Fraguas D; Parellada M
    J Am Acad Child Adolesc Psychiatry; 2014 Nov; 53(11):1179-90,1190.e1-4. PubMed ID: 25440308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.